Dingdang Health cancels 14.34 million shares and repurchases 0.20 million more, cutting outstanding stock by 1.14%

Bulletin Express07-16

Dingdang Health Technology Group Ltd. reported to the Hong Kong Stock Exchange that on 16 July 2026 it executed significant capital-management actions affecting its share base.

• Share cancellation: The company cancelled 14.34 million ordinary shares that had been repurchased between 19 May and 8 July 2026. This cancellation reduced the number of issued shares (excluding treasury shares) by 1.14%, from 1.25 billion to 1.24 billion.

• New buyback: On 16 July 2026 Dingdang Health repurchased an additional 0.20 million shares on the Exchange at prices ranging from HKD 0.90 to HKD 0.92, for a total consideration of HKD 0.18 million. These shares are being held as treasury stock.

• Post-transaction share capital: – Issued shares (excluding treasury shares): 1.24 billion – Treasury shares: 0.88 million – Total issued shares (including treasury shares): 1.24 billion

• Repurchase mandate status: – Authorisation granted on 23 June 2026 allows the company to buy back up to 124.32 million shares. – Cumulative repurchases under the mandate now total 3.74 million shares, equal to 0.30% of the issued share capital on the mandate date. – A 30-day moratorium on issuing new shares or disposing of treasury shares applies until 15 August 2026.

The company confirmed that all transactions complied with Hong Kong listing rules and relevant legal requirements.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1123529992?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-07-16 18:23","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1123529992","market":"us","top_or_hot":-1,"title":"Dingdang Health cancels 14.34 million shares and repurchases 0.20 million more, cutting outstanding stock by 1.14%","media":"Bulletin Express","content":"<p>Dingdang Health Technology Group Ltd. reported to the Hong Kong Stock Exchange that on 16 July 2026 it executed significant capital-management actions affecting its share base.</p>\n<p>• Share cancellation: The company cancelled 14.34 million ordinary shares that had been repurchased between 19 May and 8 July 2026. This cancellation reduced the number of issued shares (excluding treasury shares) by 1.14%, from 1.25 billion to 1.24 billion.</p>\n<p>• New buyback: On 16 July 2026 Dingdang Health repurchased an additional 0.20 million shares on the Exchange at prices ranging from HKD 0.90 to HKD 0.92, for a total consideration of HKD 0.18 million. These shares are being held as treasury stock.</p>\n<p>• Post-transaction share capital:  \n  – Issued shares (excluding treasury shares): 1.24 billion  \n  – Treasury shares: 0.88 million  \n  – Total issued shares (including treasury shares): 1.24 billion</p>\n<p>• Repurchase mandate status:  \n  – Authorisation granted on 23 June 2026 allows the company to buy back up to 124.32 million shares.  \n  – Cumulative repurchases under the mandate now total 3.74 million shares, equal to 0.30% of the issued share capital on the mandate date.  \n  – A 30-day moratorium on issuing new shares or disposing of treasury shares applies until 15 August 2026.</p>\n<p>The company confirmed that all transactions complied with Hong Kong listing rules and relevant legal requirements.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Dingdang Health cancels 14.34 million shares and repurchases 0.20 million more, cutting outstanding stock by 1.14%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nDingdang Health cancels 14.34 million shares and repurchases 0.20 million more, cutting outstanding stock by 1.14%\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-07-16 18:23</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Dingdang Health Technology Group Ltd. reported to the Hong Kong Stock Exchange that on 16 July 2026 it executed significant capital-management actions affecting its share base.</p>\n<p>• Share cancellation: The company cancelled 14.34 million ordinary shares that had been repurchased between 19 May and 8 July 2026. This cancellation reduced the number of issued shares (excluding treasury shares) by 1.14%, from 1.25 billion to 1.24 billion.</p>\n<p>• New buyback: On 16 July 2026 Dingdang Health repurchased an additional 0.20 million shares on the Exchange at prices ranging from HKD 0.90 to HKD 0.92, for a total consideration of HKD 0.18 million. These shares are being held as treasury stock.</p>\n<p>• Post-transaction share capital:  \n  – Issued shares (excluding treasury shares): 1.24 billion  \n  – Treasury shares: 0.88 million  \n  – Total issued shares (including treasury shares): 1.24 billion</p>\n<p>• Repurchase mandate status:  \n  – Authorisation granted on 23 June 2026 allows the company to buy back up to 124.32 million shares.  \n  – Cumulative repurchases under the mandate now total 3.74 million shares, equal to 0.30% of the issued share capital on the mandate date.  \n  – A 30-day moratorium on issuing new shares or disposing of treasury shares applies until 15 August 2026.</p>\n<p>The company confirmed that all transactions complied with Hong Kong listing rules and relevant legal requirements.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"09886","symbol_name":"叮当健康","start_time":0,"source_url":"","article_id":"1123529992","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1123529992","pubTimestamp":1784197398,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Dingdang Health Technology Group Ltd. reported to the Hong Kong Stock Exchange that on 16 July 2026 it executed significant capital-management actions affecting its share base. • Share cancellation:...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"09886":"叮当健康"},"translate_title":"叮当健康注销1434万股，再回购20万股，流通股减少1.14%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"09886":1},"content_text":"Dingdang Health Technology Group Ltd. reported to the Hong Kong Stock Exchange that on 16 July 2026 it executed significant capital-management actions affecting its share base.\n• Share cancellation: The company cancelled 14.34 million ordinary shares that had been repurchased between 19 May and 8 July 2026. This cancellation reduced the number of issued shares (excluding treasury shares) by 1.14%, from 1.25 billion to 1.24 billion.\n• New buyback: On 16 July 2026 Dingdang Health repurchased an additional 0.20 million shares on the Exchange at prices ranging from HKD 0.90 to HKD 0.92, for a total consideration of HKD 0.18 million. These shares are being held as treasury stock.\n• Post-transaction share capital:  \n  – Issued shares (excluding treasury shares): 1.24 billion  \n  – Treasury shares: 0.88 million  \n  – Total issued shares (including treasury shares): 1.24 billion\n• Repurchase mandate status:  \n  – Authorisation granted on 23 June 2026 allows the company to buy back up to 124.32 million shares.  \n  – Cumulative repurchases under the mandate now total 3.74 million shares, equal to 0.30% of the issued share capital on the mandate date.  \n  – A 30-day moratorium on issuing new shares or disposing of treasury shares applies until 15 August 2026.\nThe company confirmed that all transactions complied with Hong Kong listing rules and relevant legal requirements.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding,SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.46.0","shortVersion":"4.46.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1123529992","isCrawlerRequest":true}